Early Levothyroxine Post Radioactive Iodine

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Graves' Disease
Interventions
DRUG

Levothyroxine

Early initiation of levothyroxine after radioactive iodine (to start at 4 weeks).

OTHER

Placebo

Placebo to start at 4 weeks after RAI

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01950260 - Early Levothyroxine Post Radioactive Iodine | Biotech Hunter | Biotech Hunter